Associated Press Highlights Clinical Trial Results Conducted at Temple MDA/ALS Center of Hope and Led by Dr. Terry Heiman-Patterson

Pison has announced the results of a recent clinical trial conducted by researchers at the Temple MDA/ALS Center of Hope, which concluded that the company’s Neural Biosensor hardware and electroneurography (ENG) technology was able to distinguish patients with ALS from those without the condition and detect changes in surface electromyography in those with ALS – reflecting motor neuron changes correlated with functional changes. The study was led by Terry Heiman-Patterson, MD, Professor of Neurology at the Lewis Katz School of Medicine at Temple University and Director of the Temple MDA/ALS Center of Hope. The Associated Press highlighted the news and included comments from Dr. Heiman-Patterson.